'Kam Risk Mein Pharma Stauks Se Milega Tagada Return

Business »

'Kam Risk Mein Pharma Stauks Se Milega Tagada Return

iti naau ko diye interview mein Religare kaipitl maarkets ke emadi aur head of ikviteej-India, Gautam trivedi ne market mein giraavat aur sheyaron par charcha ki. Unhonne kuchh stauks aur sectoron par apni rai rakhi: Aap is maheene market mein giraavat ke liye global seling ya kharaab maikro-ikanaumi ya kharaab praufit vijibiliti mein se kise vajah maanate hain? Market mein in sabhi vajahon se giraavat I hai. India aur imarjing maarkets mein inavestar ki dilchaspi is saal ke shuruaati maheenon mein kaafi dikhi thi. Haalaanki, pichhle 15-20 dinon mein mid-kaip stauks mein seling shuroo hone ke baad inavestars ka intarest kaafi kam huaa hai. Is saal global maarkets mein Japan fevaret raha hai. Fauren inavestars ka focus ab Japan par hai. Isse Japani stock market dollar tarm mein 11 feesadi tak chadha hai. Rupae tarm mein ismein kareeb 27 feesadi ki teji I hai. Is saal ke pehle teen maheenon mein Japan ke stock market mein kareeb 40 arab dollar ka inavestameint huaa, jo pichhle saal se 100 feesadi jyaada hai. Aise mein focus yahaan se shift huaa hai. Isse Indian market mein giraavat I hai. Market 10 feesadi girkar haal ke 6000 ke haai leval se 5500 par aa gaya hai. Aapko aur kitni giraavat ki aashanka hai. Market abhi 10 feesadi aur gir sakta hai. Agar ham put aur call straaiks par najar daalein, to put ke liye ye 5400 aur call ke liye 5600-5700 hain. Aise mein in levals se market ke jyaada oopar jaane ke aasaar najar naheen aa rahe hain. Kya aap kvaaliti stauks ko lekar chintit hain, kyonki FII ne sirf aise sheyaron mein hi paisa lagaaya hai. Agar short tarm mein fauren inavestameint kam hota hai, to kya kvaaliti premium kam hoga? Yah ek risk hai, kyonki pichhle dedh maheene mein humne dekha hai ki FII keval kvaaliti stauks hi khareed rahe hain. Haalaanki, ve laung tarm inavestar hote hain. Aise mein mujhe naheen lagta ki ve haal-filhaal mein inhein becheinge. ETF seling badi chinta hai. HDFC bank jaise kuchh kvaaliti naam hain, jinmein aam taur par baaing ka mauka naheen milta hai. Is stock mein kareeb 10 feesadi ki giraavat I hai. Ek timaahi pehle dalaal street par paupular treind difeinsiv stauks ko bechana aur haai beeta vaale gire hue stauks khareedna tha. Kya aapko lagta hai ki yah treind badla hai aur kya inavestars ko difeinsiv stauks ko fir se khareedna chaahiye? Ab market ki soch badal gayi hai. Pharma abhi bhi domestik kanjampashan theem hai. Pharma stauks efaemaseeji companiyon ke mukaabale kaafi diskaaunt par chal rahe hain. Echayooel aur ITC ke mukaabale ye stauks 25-30 feesadi aur kuchh maamalon mein 35 feesadi tak diskaaunt par khareede ja sakte hain. Cadila , lyoopin , Cipla aur rainabaiksi jaise stauks kaafi atraiktiv lag rahe hain.

'Kam Risk Mein Pharma Stauks Se Milega Tagada Return https://www.angrejinews.com/pic/5074